» Articles » PMID: 1104741

T and B Cell in Hapten-specific Carrier-determined Tolerance

Overview
Journal J Exp Med
Date 1975 Nov 1
PMID 1104741
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

BDF1 mice were made tolerant by a single i.v. injection of 1 mg of DNAP-gamma1 or by weekly i.v. injections of 0.2 mg of DNP-gamma1 given for a month. In both instances, spleen cells of tolerant animals were fractionated to obtain pure populations of T cells (nonimmunoglobulin-bearing cells), referred to as tolerant T cells, and B cells (immunoglobulin-bearing cells) referred to as tolerant B cells (immunoglobulin-bearing cells) referred to as tolerant B cells. The control cells were similarly fractionated to obtain normal T and B cells. Mixtures of tolerant T cells and normal B cells, or conversely, normal T cells and tolerant B cells were used to repopulate lethally irradiated recipients. These recipients were then immunized with dinitrophenyl-keyhole limpet haemocyanin and in certain instances with other antigen horse red blood cells. The immune response to both antigens was measured using the direct hemolytic plaque assay. It was found that both T and B cells were tolerant and that tolerance was hapten specific at both T- and B-cell levels. While B-cell tolerance was demonstrated at a 1/1 T/B ratio, a 4/1 T/B ratio was necessary to show T-cell tolerance. Thus, the hapten-specific carrier-determined tolerance involves not only B cells but also T cells. The implication of this finding for the cellular mechanism of tolerance in an experimental model closely related to self tolerance is discussed.

Citing Articles

Induction of tolerance by administration of hapten-immunoglobulin conjugates is associated with decreased IL-2 and IL-4 production.

Dumas V, Ptak W, Demarchez M, Saurat J, Borel Y, Hauser C Arch Dermatol Res. 1995; 287(2):123-8.

PMID: 7763082 DOI: 10.1007/BF01262319.


A natural model of immunologic tolerance. Tolerance to murine C5 is mediated by T cells, and antigen is required to maintain unresponsiveness.

Harris D, Cairns L, Rosen F, Borel Y J Exp Med. 1982; 156(2):567-84.

PMID: 6808076 PMC: 2186765. DOI: 10.1084/jem.156.2.567.


From nonspecific to specific immunosuppression: facts and speculation.

Borel Y Springer Semin Immunopathol. 1984; 7(1):19-24.

PMID: 6204394 DOI: 10.1007/BF01891776.


Hapten-specific T-cell unresponsiveness induced bybenzylpenicilloyl autologous gamma globulin conjugates in human lymphocyes in vitro.

Geha R, Fruchter L, Borel Y J Clin Invest. 1980; 65(6):1509-14.

PMID: 6157701 PMC: 371490. DOI: 10.1172/JCI109816.


Dichotomy between the induction of suppressor cells and immunologic tolerance by adult thymectomy.

Borel Y, Kilham L, Kurtz S, Reinisch C J Exp Med. 1980; 151(3):743-8.

PMID: 6153696 PMC: 2185794. DOI: 10.1084/jem.151.3.743.


References
1.
Cohen I, Wekerle H . Regulation of autosensitization. The immune activation and specific inhibition of self-recognizing thymus-derived lymphocytes. J Exp Med. 1973; 137(2):224-38. PMC: 2139474. DOI: 10.1084/jem.137.2.224. View

2.
Feldmann M . Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellin. J Exp Med. 1972; 135(4):735-53. PMC: 2139147. DOI: 10.1084/jem.135.4.735. View

3.
Feldmann M . Induction of immunity and tolerance in vitro by hapten protein conjugates. 3. Hapten inhibition studies of antigen binding to B cells in immunity and tolerance. J Exp Med. 1972; 136(3):532-45. PMC: 2139255. DOI: 10.1084/jem.136.3.532. View

4.
Golan D, Borel Y . Nonantigenicity and immunologic tolerance: the role of the carrier in the induction of tolerance to the hapten. J Exp Med. 1971; 134(4):1046-61. PMC: 2138999. DOI: 10.1084/jem.134.4.1046. View

5.
Chiller J, Habicht G, Weigle W . Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science. 1971; 171(3973):813-5. DOI: 10.1126/science.171.3973.813. View